Women's Cancer News
Oct. 16, 2013

Targeted treatment plus chemotherapy could benefit women with ovarian cancer
Medical Xpress
Conventional chemotherapy could further extend life in some women with ovarian cancer when used in tandem with a new type of targeted treatment, a new international study shows. The research, published in the October issue of the journal Clinical Cancer Research, provides important evidence that PARP inhibitor drugs and chemotherapy can both be effective in the same patients, helping women live longer than they would if treated with chemotherapy alone.More

Communication factors aid cancer diagnosis disclosure
HealthDay News via Doctors Lounge
Ensuring disclosure of a gynecological cancer diagnosis takes place in a private setting and that the conversation lasts for more than 10 minutes improves patient satisfaction, according to a study published online in Obstetrics & Gynecology. Lindsay M. Kuroki, M.D., from the Washington University School of Medicine in St. Louis, and colleagues surveyed 100 gynecologic oncology patients using an 83-item tool based on evaluated patient-centered factors, physician behavior and communication skills, and environmental factors.More

Genomic differences observed in cervical cancer subtypes
Healio
The two most common subtypes of cervical cancer harbor high rates of potentially targetable oncogenic mutations, study results suggest. Because cervical adenocarcinomas and squamous cell carcinoma feature distinct molecular profiles, personalized treatment strategies could significantly improve outcomes, researchers wrote.More

Breaking through cancer's shield
The New York Times
For more than a century, researchers were puzzled by the uncanny ability of cancer cells to evade the immune system. They knew cancer cells were grotesquely abnormal and should be killed by white blood cells. In the laboratory, in Petri dishes, white blood cells could go on the attack against cancer cells. Why, then, could cancers survive in the body? The answer, when it finally came in recent years, arrived with a bonus: a way to thwart a cancer's strategy. Researchers discovered that cancers wrap themselves in an invisible protective shield. And they learned that they could break into that shield with the right drugs.More

HPV in women who have sex with women: NPs & PAs must provide screening and education
ADVANCE
The population of women who have sex with women is composed of several demographic groups: lesbians, bisexual women and women who self-identify as heterosexual but have had sexual experiences with women. Estimates about how many women are in any of these groups are difficult to obtain, but approximately 4 percent to 10 percent of U.S. women describe themselves as lesbians,1-3 which is about 2.3 million women.4 This is comparable to estimates from a recent British survey reporting 4.9 percent of women have had same sex partners,5 and somewhat lower than an Australian telephone survey that reported 15.1 percent of women with same sex attraction or experience.More

Debt default could delay Medicare/Medicaid pay
Medscape (Free login required)
A government default on the United States' financial obligations — the consequence of not raising the debt ceiling by Oct. 17 — would delay Medicare and Medicaid reimbursement to physicians and other healthcare providers, Treasury Secretary Jacob "Jack" Lew told the Senate Finance Committee.More

Doctors search for vaccine to prevent breast cancer
USA Today
Forty years ago, women who had abnormal results on a Pap smear often wound up with a hysterectomy. Doctors removed their uterus because they had no other way to prevent women from developing cervical cancer, researcher Susan Love says. Today, she says, doctors can prevent cervical cancer with a vaccine. That has led some to ask: Could researchers develop a vaccine against breast cancer? More